Healios KK (HLOSF)
1.50
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Healios Gross Profit Margin (Quarterly): 86.35% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 86.35% |
March 31, 2024 | |
December 31, 2023 | |
September 30, 2023 | |
June 30, 2023 | 88.00% |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 |
Date | Value |
---|---|
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | 85.72% |
March 31, 2017 | 90.00% |
December 31, 2016 | 88.53% |
September 30, 2016 | 88.00% |
June 30, 2016 | 88.00% |
March 31, 2016 | 88.32% |
December 31, 2015 | 87.94% |
September 30, 2015 | 88.00% |
June 30, 2015 | 94.12% |
March 31, 2015 | 88.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
86.35%
Minimum
Jun 2024
88.00%
Maximum
Jun 2023
87.17%
Average
87.17%
Median
Gross Profit Margin (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 66.47% |
Nxera Pharma Co Ltd | 78.44% |
PeptiDream Inc | 89.26% |
AnGes Inc | 31.07% |
SanBio Co Ltd | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -137.2% |
Return on Assets | -33.10% |
Return on Invested Capital | -55.94% |
Profit Margin (Quarterly) | -107.2% |
Operating Margin (Quarterly) | -56.63% |
Return on Net Operating Assets | -106.6% |